Omicron variant-specific vaccine
Scope
Date
~
-
Korean chipmakers
Samsung ‘demanding customer’ for ASML as orders rise
VELDHOVEN, Netherlands – South Korea’s Samsung Electronics Co. is a “demanding customer” for the Netherlands-based ASML Hold...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Ochang facility gets WHO PQ certification
GC Biopharma Co.'s production facility in Ochang (North Chungcheong Province) secured a pre-qualification (PQ) certification from the World Health O...
Feb 10, 2023 (Gmt+09:00)
-
Artificial intelligence
Kakao to unveil Korean language-specific, vertical AI
Kakao Corp., South Korea’s No. 1 mobile messenger platform, will launch Korean language-specific, vertically-integrated AI service this year s...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Red ginseng prevents flu, pneumonia: research
Studies have shown that South Korea's hongsam (red ginseng) is effective in preventing respiratory diseases such as the flu and pneumonia.The Korean...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved by Chilean health authority
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadr...
Feb 02, 2023 (Gmt+09:00)
-
Automobiles
Kia launches 2024 Niro model with enhanced features
Kia Corp. announced on Wednesday the launch of the 2024 Niro, a compact crossover SUV hybrid and electric vehicle (EV) models, which will be availab...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's shingles vaccine obtains product approval from Malaysia
SK Bioscience Co. said on Monday that its shingles vaccine Sky Zoster has been given approval by Malaysia's National Pharmaceutical Regulatory Age...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
KOICA donates Celltrion's Herzuma to Ukraine
Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
HLB Therapeutics signs contract for COVID vaccine distribution rights
South Korea's pharmaceutical firm HLB Therapeutics Co. said on Monday that it has signed an agreement with the Korea Disease Control and Prevention ...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
LG Uplus to debut university-specific metaverse platforms early next year
South Korea's mobile telecom operator LG Uplus said on Thursday that it would introduce a specialized metaverse platform for which all universities ...
Dec 15, 2022 (Gmt+09:00)
-
Artificial intelligence
LG Group think tank unveils breakthrough AI tech Exaone
LG AI Research, the artificial intelligence (AI) think tank of South Korea's LG Group, on Thursday unveiled Exaone, a gigantic AI technology that ra...
Dec 09, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience seeks WHO nod for prompt COVID vaccine sale
SK Bioscience Co., the biopharmaceutical unit of South Korea’s No. 2 conglomerate SK Group, sought approval from the World Health Organization...
Sep 08, 2022 (Gmt+09:00)
-
Corporate governance
Activist fund steps up pressure for SM Ent's governance reform
Align Partners Capital Management, a South Korean activist fund, has threatened legal action against entertainment behemoth SM Entertainment Co., re...
Aug 18, 2022 (Gmt+09:00)
-
Korean chipmakers
Samsung presents Texas with $200 bn chip investment plan proposition
Samsung Electronics Co., the world’s top memory chipmaker, has presented a tax break proposal to the State of Texas as part of its plan to inv...
Jul 22, 2022 (Gmt+09:00)
-
Corporate investment
Korea to raise cash support on foreign investments in key sectors
South Korea plans to spend more cash on attracting foreign investments in high-tech and core supply chain industries as foreign direct investment to...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
Korean startups
Startups serving specific markets thrive: SaaS, fantech, veganism
Vertical service providers are dominating South Korea’s venture business ecosystem, in a study of the country’s early stage startups by ...
Jun 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience becomes first to win domestic COVID-19 vaccine contract
SK Bioscience Co. said it reached a deal with Korea’s disease control agency to supply 10 million doses of the country’s first experimen...
Mar 22, 2022 (Gmt+09:00)
language -
Entertainment
BTS returns to Korean stage for 1st time since 2019
SEOUL — In the latest sign that life is going back to something that resembles the pre-pandemic past, BTS is returning to the stage in Seoul.The...
Feb 25, 2022 (Gmt+09:00)
-
Korean stock market
Korea’s reopening stocks shine despite surging Omicron cases
South Korea’s reopening stocks rallied even as the local COVID-19 cases hit record-highs with the spread of the Omicron variant. Investors rai...
Feb 08, 2022 (Gmt+09:00)
-
Earnings
SK Bioscience posts record earnings driven by COVID-19 vaccines
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, has posted record 2021 revenue and operating profit, boosted by contrac...
Feb 08, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...
Dec 24, 2021 (Gmt+09:00)
language -
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Pharamaceuticals, biotech
Celltrion to conduct tests on Omicron variant detected in Korea
Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...
Dec 06, 2021 (Gmt+09:00)
-
Aerospace & Defense
Korea’s Hanwha Aerospace to develop small rocket system
Hanwha Aerospace Co., a unit of South Korean conglomerate Hanwha Group, is developing system technology for small projectiles that launch a satellit...
Dec 06, 2021 (Gmt+09:00)
-
COVID-19
Korea’s reopening stocks jump on easing Omicron woes
South Korea’s reopening stocks surged on Dec. 3 as US President Joe Biden’s plans to curb the Omicron variant of COVID-19 exclude lockdo...
Dec 03, 2021 (Gmt+09:00)